SEC Form 4 · accession 0001140361-18-031743
NRC HEALTH · NRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 3, 2018
Accepted (ET)
Jul 6, 2018 · 1:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 3, 2018 | S | 1,305 | $38.0001 | D | 5,729,418 | D | |
| Common StockF3 | Jul 5, 2018 | S | 6,414 | $38.0039 | D | 5,723,004 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.075, inclusive. The Reporting Person undertakes to provide National Research Corp. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Remarks
This Form 4 is being filed by the K/I/E/Trust Under Agreement 3/9/09, f/k/a Michael and Karen Hays Grandchildren's Trust Dated March 9, 2009, and by Kent E. Endacott, as Special Holdings Direction Adviser under the K/I/E/Trust Under Agreement 3/9/09.